Mazor Robotics (NASDAQ:MZOR) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Friday.
MZOR has been the subject of a number of other research reports. Zacks Investment Research downgraded Mazor Robotics from a “buy” rating to a “hold” rating in a report on Saturday, January 13th. Vetr downgraded Mazor Robotics from a “hold” rating to a “sell” rating and set a $66.27 price objective for the company. in a report on Thursday, March 8th. Finally, Barclays reiterated a “sell” rating and issued a $36.00 price objective on shares of Mazor Robotics in a report on Tuesday, January 9th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $49.21.
Shares of Mazor Robotics (NASDAQ:MZOR) opened at $59.50 on Friday. Mazor Robotics has a fifty-two week low of $25.24 and a fifty-two week high of $76.56.
Several institutional investors have recently made changes to their positions in MZOR. IFP Advisors Inc increased its holdings in shares of Mazor Robotics by 87.2% in the fourth quarter. IFP Advisors Inc now owns 2,275 shares of the medical instruments supplier’s stock worth $117,000 after acquiring an additional 1,060 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Mazor Robotics by 72.4% in the fourth quarter. Envestnet Asset Management Inc. now owns 2,659 shares of the medical instruments supplier’s stock worth $137,000 after acquiring an additional 1,117 shares in the last quarter. Advisor Group Inc. increased its holdings in shares of Mazor Robotics by 365.8% in the third quarter. Advisor Group Inc. now owns 2,795 shares of the medical instruments supplier’s stock worth $138,000 after acquiring an additional 2,195 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. increased its holdings in shares of Mazor Robotics by 107.3% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,811 shares of the medical instruments supplier’s stock worth $188,000 after acquiring an additional 1,973 shares in the last quarter. Finally, Dumont & Blake Investment Advisors LLC bought a new stake in shares of Mazor Robotics in the fourth quarter worth about $258,000. Institutional investors own 23.98% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Mazor Robotics (MZOR) Stock Rating Lowered by BidaskClub” was reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3299295/mazor-robotics-mzor-stock-rating-lowered-by-bidaskclub.html.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include Renaissance Guidance System, which can improve the execution and outcomes in a wide variety of procedures, including percutaneous degenerative repair, pedicle screw fixation for complex spinal deformity, and vertebral augmentation; Mazor X, the Surgical Assurance Platform for Spine Surgery.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.